Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis. [electronic resource] by
- Baz, Rachid
- Patel, Mehul
- Finley-Oliver, Elizabeth
- Lebovic, Daniel
- Hussein, Mohamad A
- Miller, Kena C
- Wood, Margaret
- Sher, Taimur
- Lee, Kelvin
- Chanan-Khan, Asher A
Producer: 20100927
In:
Leukemia & lymphoma vol. 51
Availability: No items available.
|
|
6.
|
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. [electronic resource] by
- Advani, Ranjana H
- Lebovic, Daniel
- Chen, Andy
- Brunvand, Mark
- Goy, Andre
- Chang, Julie E
- Hochberg, Ephraim
- Yalamanchili, Sreeni
- Kahn, Robert
- Lu, Dan
- Agarwal, Priya
- Dere, Randall C
- Hsieh, Hsin-Ju
- Jones, Surai
- Chu, Yu-Waye
- Cheson, Bruce D
Producer: 20180209
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
7.
|
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab. [electronic resource] by
- Elstrom, Rebecca L
- Ruan, Jia
- Christos, Paul J
- Martin, Peter
- Lebovic, Daniel
- Osborne, Joseph
- Goldsmith, Stanley
- Greenberg, June
- Furman, Richard R
- Avram, Anca
- Putman, Ryan
- Chapman, Erica
- Mazumdar, Madhu
- Griffith, Kent
- Coleman, Morton
- Leonard, John P
- Kaminski, Mark S
Producer: 20160401
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
8.
|
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. [electronic resource] by
- Shah, Jatin J
- Jakubowiak, Andrzej J
- O'Connor, Owen A
- Orlowski, Robert Z
- Harvey, R Donald
- Smith, Mitchell R
- Lebovic, Daniel
- Diefenbach, Catherine
- Kelly, Kevin
- Hua, Zhaowei
- Berger, Allison J
- Mulligan, George
- Faessel, Hélène M
- Tirrell, Stephen
- Dezube, Bruce J
- Lonial, Sagar
Producer: 20161013
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
9.
|
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. [electronic resource] by
- Li, Hongxiu
- Kaminski, Mark S
- Li, Yifeng
- Yildiz, Mehmet
- Ouillette, Peter
- Jones, Siân
- Fox, Heather
- Jacobi, Kathryn
- Saiya-Cork, Kamlai
- Bixby, Dale
- Lebovic, Daniel
- Roulston, Diane
- Shedden, Kerby
- Sabel, Michael
- Marentette, Lawrence
- Cimmino, Vincent
- Chang, Alfred E
- Malek, Sami N
Producer: 20140509
In:
Blood vol. 123
Availability: No items available.
|
|
10.
|
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma. [electronic resource] by
- Richardson, Paul G
- Hofmeister, Craig C
- Rosenbaum, Cara A
- Htut, Myo
- Vesole, David H
- Berdeja, Jesus G
- Liedtke, Michaela
- Chari, Ajai
- Smith, Stephen D
- Lebovic, Daniel
- Raje, Noopur
- Byrne, Catriona
- Liao, Eileen
- Gupta, Neeraj
- Bacco, Alessandra Di
- Estevam, Jose
- Berg, Deborah
- Baz, Rachid
Producer: 20190603
In:
British journal of haematology vol. 182
Availability: No items available.
|
|
11.
|
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. [electronic resource] by
- Jakubowiak, Andrzej J
- Dytfeld, Dominik
- Griffith, Kent A
- Lebovic, Daniel
- Vesole, David H
- Jagannath, Sundar
- Al-Zoubi, Ammar
- Anderson, Tara
- Nordgren, Brian
- Detweiler-Short, Kristen
- Stockerl-Goldstein, Keith
- Ahmed, Asra
- Jobkar, Terri
- Durecki, Diane E
- McDonnell, Kathryn
- Mietzel, Melissa
- Couriel, Daniel
- Kaminski, Mark
- Vij, Ravi
Producer: 20121207
In:
Blood vol. 120
Availability: No items available.
|
|
12.
|
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma. [electronic resource] by
- Dytfeld, Dominik
- Jasielec, Jagoda
- Griffith, Kent A
- Lebovic, Daniel
- Vesole, David H
- Jagannath, Sundar
- Al-Zoubi, Ammar
- Anderson, Tara
- Detweiler-Short, Kristen
- Stockerl-Goldstein, Keith
- Ahmed, Asra
- Jobkar, Terri
- Durecki, Diane E
- McDonnell, Kathryn
- Mietzel, Melissa
- Couriel, Daniel
- Kaminski, Mark
- Vij, Ravi
- Jakubowiak, Andrzej J
Producer: 20150406
In:
Haematologica vol. 99
Availability: No items available.
|
|
13.
|
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. [electronic resource] by
- Richardson, Paul G
- Bensinger, William I
- Huff, Carol Ann
- Costello, Caitlin L
- Lendvai, Nikoletta
- Berdeja, Jesus G
- Anderson, Larry D
- Siegel, David S
- Lebovic, Daniel
- Jagannath, Sundar
- Laubach, Jacob P
- Stockerl-Goldstein, Keith E
- Kwei, Long
- Clow, Fong
- Elias, Laurence
- Salman, Zeena
- Graef, Thorsten
- Bilotti, Elizabeth
- Vij, Ravi
Producer: 20190205
In:
British journal of haematology vol. 180
Availability: No items available.
|
|
14.
|
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. [electronic resource] by
- Lesokhin, Alexander M
- Ansell, Stephen M
- Armand, Philippe
- Scott, Emma C
- Halwani, Ahmad
- Gutierrez, Martin
- Millenson, Michael M
- Cohen, Adam D
- Schuster, Stephen J
- Lebovic, Daniel
- Dhodapkar, Madhav
- Avigan, David
- Chapuy, Bjoern
- Ligon, Azra H
- Freeman, Gordon J
- Rodig, Scott J
- Cattry, Deepika
- Zhu, Lili
- Grosso, Joseph F
- Bradley Garelik, M Brigid
- Shipp, Margaret A
- Borrello, Ivan
- Timmerman, John
Producer: 20170726
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34
Availability: No items available.
|